Symbols

RDHL

Redhill Biopharma·NASDAQ

--(--)

7.08 / 10

Outperform

Analyst input is unavailable (ana_eval -1). Fund‑flow score is 7.08/10, classified good. Small‑cap inflows are positive, but overall, block, medium, large, and extra‑large flows are negative, indicating mixed money movement despite a decent aggregate score.

Fund Flow Rating

What is the market sentiment for RDHL?

RDHL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.08/10 (Outperform).